BIP Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.82M Sell
3,064
-609
-17% -$617K 0.11% 114
2025
Q4
$3.95M Buy
3,673
+2,268
+161% +$2.17M 0.14% 100
2025
Q3
$1.07M Buy
1,405
+520
+59% +$387K 0.05% 120
2025
Q2
$690K Sell
885
-120
-12% -$93.2K 0.04% 129
2025
Q1
$830K Sell
1,005
-131
-12% -$109K 0.05% 112
2024
Q4
$877K Buy
1,136
+148
+15% +$123K 0.06% 109
2024
Q3
$875K Buy
988
+237
+32% +$213K 0.06% 99
2024
Q2
$680K Sell
751
-194
-21% -$155K 0.06% 97
2024
Q1
$735K Buy
945
+49
+5% +$34.9K 0.05% 103
2023
Q4
$522K Buy
896
+280
+45% +$163K 0.04% 114
2023
Q3
$331K Sell
616
-89
-13% -$45.9K 0.03% 128
2023
Q2
$331K Sell
705
-20
-3% -$8.39K 0.03% 131
2023
Q1
$249K Buy
+725
New +$245K 0.03% 156

Other funds holding LLY

BIP Wealth's LLY Position: Q1 2026 in Review

BIP Wealth reduced its Eli Lilly (LLY) stake by 17% in Q1 2026, selling an estimated $617K and leaving 3,064 shares worth $2.82M. The position accounts for 0.11% of the portfolio, ranked #114.

BIP Wealth first reported a position in LLY in Q1 2023 and has held it in 13 quarters since. The position peaked at $3.95M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • BIP Wealth held 3,064 shares of Eli Lilly worth $2.82M as of Q1 2026.
  • BIP Wealth sold 609 Eli Lilly shares in Q1 2026, an estimated $617K.
  • Eli Lilly made up 0.11% of BIP Wealth's portfolio in Q1 2026, its #114 holding.
  • BIP Wealth first reported a position in Eli Lilly in Q1 2023 and has held it in 13 quarters since.
  • BIP Wealth's Eli Lilly position peaked at $3.95M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on BIP Wealth's 13F filing for Q1 2026, filed 27 Apr 2026.